Glaxosmithkline's HIV jab is approved by US regulators

The Food and Drug Administration became the first regulator to approve cabotegravir, which is marketed under the name Apretude.

Related Keywords

Japan ,United States ,Japanese ,American ,Debra Birnkrant ,Deborah Waterhouse ,Glaxosmithkline ,National Institute For Health ,Pfizer ,Drug Administration ,Viiv Healthcare ,National Institute ,Care Excellence ,Dailymail ,Money ,Moneymarkets ,